Matisse Pharmaceuticals B.V.
matissepharmaceuticals.com
Biotechnology
Matisse Pharmaceuticals B.V. is developing treatments aimed at effectively neutralizing cytotoxic histones to address severe medical conditions like sepsis. The company focuses on innovative therapies to improve patient outcomes.
Founded
2014
Total Funding
$10M+
Total Rounds
1
First Raise
Sep 17, 2026
Latest Raise
Sep 17, 2026
Get notified when Matisse Pharmaceuticals B.V. and companies like it raise
New funding rounds in your inbox every week 路 No noise, all Signal.
Organization Chart
Founders and leadership hierarchy for this company.
Contact details require Sales or Enterprise
Open Roles
Loading open roles...
All Funding Rounds
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 9/17/2026 | |||
Company Performance Metrics
Premium Feature
Upgrade to Premium to view Capital Momentum Score and performance metrics
Matisse Pharmaceuticals B.V. 路 Never miss the next round
Who's raising next?
New funding rounds in your inbox every week 路 Free